Chiari–Frommel syndrome

Lore & Background

Chiari–Frommel syndrome describes a condition where women experience persistent galactorrhea and amenorrhea after childbirth, linked to elevated prolactin levels. Prolactin is a peptide hormone produced by lactotroph cells in the anterior pituitary gland, crucial for milk production during pregnancy and lactation. After childbirth, the rapid decline in estrogen and progesterone levels allows lactation to begin, but in this syndrome, prolactin remains abnormally high, suppressing gonadotropin secretion and delaying ovulation.

Reader's Guide

The significance of Chiari–Frommel syndrome lies in its illustration of how hyperprolactinemia can disrupt reproductive function. In women, high prolactin levels are typically associated with hypoestrogenism, anovulatory infertility, and changes in menstruation, such as amenorrhea or oligomenorrhea. Galactorrhea may occur but is not always present; many pre-menopausal women with hyperprolactinemia do not experience galactorrhea, and some women with galactorrhea have normal prolactin levels. The syndrome highlights the complex regulation of prolactin, which is primarily inhibited by hypothalamic dopamine, and how disruption of this regulation can lead to prolonged postpartum symptoms. Long-term hyperprolactinemia can also lead to detrimental changes in bone metabolism due to hypoestrogenism, increasing risk of osteoporosis.

Did You Know?

• In women, normal prolactin levels average about 13 ng/mL, while in men they average 5 ng/mL.
• Prolactin secretion is primarily regulated by hypothalamic inhibition, unlike most anterior pituitary hormones.
• Hyperprolactinemia can result from normal physiological changes during pregnancy and breastfeeding.
• Galactorrhea may be observed in individuals with normal prolactin levels and does not necessarily indicate hyperprolactinemia.